AB Science granted authorization to initiate confirmatory :

PRESS RELEASE AB SCIENCE HAS BEEN AUTHORIZED BY THE SWEDISH MEDICAL PRODUCTS AGENCY TO INITIATE CONFIRMATORY PHASE III TRIAL OF MASITINIB IN PROGRESSIVE...

Related Keywords

France , Sweden , United States , Paris , France General , French , Swedish , Arthur Rouill , Scler Frontotemporal Degener , Kate Barrette , Olivier Hermine , Hermineo Masitinib , French Medicine Agency , Americas Committee For Treatment , Swedish Medical Products Agency , Research In Multiple Sclerosis , Scientific Committee , European Committee For Treatment , Primary Progressive Multiple Sclerosis , Secondary Progressive Multiple Sclerosis , Compare Efficacy , Masitinib Dose Titration , Primary Progressive , Secondary Progressive Multiple Sclerosis Without , Des Sciences , Expanded Disability Status Scale , Joint Americas Committee , Multiple Sclerosis , European Committee , Lateral Scler Frontotemporal , Adv Neurol , Euronext Paris , Paris Stock Exchange Ab , Ab Science , Asitinib , Eurology , Cl 233 Rose En Plaques , Eurologie ,